Ikuko Kato1,2, Jun Sun3, Joseph Larson4, Theresa Hastert1, Judith Abrams1. 1. Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA. 2. Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan, USA. 3. Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA. 4. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Abstract
Background and Objective: Both periodontal disease and inflammatory bowel disease (IBD), are chronic inflammatory conditions, which are mediated by a complex interplay among a dysbiotic microbiota, dysregulated host immune-inflammatory responses, and lifestyle factors. Despite substantial differences in physical and chemical environments, rather strong correlations have been detected between microbial compositions of the oral cavity and stool. In this study, we tested the hypothesis that oral health conditions are affected by the presence of IBD. Materials and Methods: We analyzed the data from 73,621 women who were enrolled in the Women's Health Initiative observational cohort study and completed a follow-up questionnaire that surveyed oral health status specifically at year 5. Among these, 880 reported IBD at the baseline, including 47% who were symptomatic cases and 27% who were on immunosuppressive treatment. We estimated odds ratios (ORs) and 95% confidence intervals (CIs) for the association of IBD and medication status for self-reported oral health outcomes, using logistic regression models, adjusted for selected covariates. Results: IBD was not associated with periodontal disease history itself in a multivariable model; however, poorer self-rated oral health was modestly associated with the presence of IBD (OR = 1.15, 95% CI: 1.01-1.30). Likewise, more frequent eating limitations due to teeth were associated with the presence of IBD history (OR = 1.22, 95% CI: 1.07-1.39). When IBD cases were limited to those who were symptomatic, the associations with these two self-rated oral health outcomes were more pronounced with ORs of 1.28 (95% CI: 1.07-1.54) and 1.36 (95% CI: 1.07-1.54), respectively. Immunosuppressive treatment had little effect on these risk estimates. Conclusions: Among this nation-wide cohort of women 50-79 years of age, history of IBD was associated with poorer perceived oral health status.
Background and Objective: Both periodontal disease and inflammatory bowel disease (IBD), are chronic inflammatory conditions, which are mediated by a complex interplay among a dysbiotic microbiota, dysregulated host immune-inflammatory responses, and lifestyle factors. Despite substantial differences in physical and chemical environments, rather strong correlations have been detected between microbial compositions of the oral cavity and stool. In this study, we tested the hypothesis that oral health conditions are affected by the presence of IBD. Materials and Methods: We analyzed the data from 73,621 women who were enrolled in the Women's Health Initiative observational cohort study and completed a follow-up questionnaire that surveyed oral health status specifically at year 5. Among these, 880 reported IBD at the baseline, including 47% who were symptomatic cases and 27% who were on immunosuppressive treatment. We estimated odds ratios (ORs) and 95% confidence intervals (CIs) for the association of IBD and medication status for self-reported oral health outcomes, using logistic regression models, adjusted for selected covariates. Results:IBD was not associated with periodontal disease history itself in a multivariable model; however, poorer self-rated oral health was modestly associated with the presence of IBD (OR = 1.15, 95% CI: 1.01-1.30). Likewise, more frequent eating limitations due to teeth were associated with the presence of IBD history (OR = 1.22, 95% CI: 1.07-1.39). When IBD cases were limited to those who were symptomatic, the associations with these two self-rated oral health outcomes were more pronounced with ORs of 1.28 (95% CI: 1.07-1.54) and 1.36 (95% CI: 1.07-1.54), respectively. Immunosuppressive treatment had little effect on these risk estimates. Conclusions: Among this nation-wide cohort of women 50-79 years of age, history of IBD was associated with poorer perceived oral health status.
Entities:
Keywords:
Women's Health Initiative; inflammatory bowel disease; oral health periodontitis
Authors: Michael J LaMonte; Kathleen M Hovey; Amy E Millen; Robert J Genco; Jean Wactawski-Wende Journal: J Periodontol Date: 2013-12-19 Impact factor: 6.993
Authors: K Agossa; A Dendooven; L Dubuquoy; C Gower-Rousseau; E Delcourt-Debruyne; M Capron Journal: J Periodontal Res Date: 2016-09-24 Impact factor: 4.419
Authors: Stephan R Vavricka; Christine N Manser; Sebastian Hediger; Marius Vögelin; Michael Scharl; Luc Biedermann; Sebastian Rogler; Frank Seibold; René Sanderink; Thomas Attin; Alain Schoepfer; Michael Fried; Gerhard Rogler; Pascal Frei Journal: Inflamm Bowel Dis Date: 2013-12 Impact factor: 5.325
Authors: Maurice W M D Lutgens; Martijn G H van Oijen; Geert J M G van der Heijden; Frank P Vleggaar; Peter D Siersema; Bas Oldenburg Journal: Inflamm Bowel Dis Date: 2013 Mar-Apr Impact factor: 5.325
Authors: Mohammad I El Mouzan; Harland S Winter; Assad A Assiri; Kirill S Korolev; Ahmad A Al Sarkhy; Scot E Dowd; Mohammad A Al Mofarreh; Rajita Menon Journal: Gut Pathog Date: 2018-11-29 Impact factor: 4.181